<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361581/" ref="ordinalpos=4321&amp;ncbi_uid=4835471&amp;link_uid=PMC3361581" image-link="/pmc/articles/PMC3361581/figure/F1/" class="imagepopup">Figure 1.  From: Differential age- and disease-related effects on the expression of genes related to the arachidonic acid <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in schizophrenia. </a></div><br /><div class="p4l_captionBody">Schematic of depiction of arachidonic acid signaling pathway highlighting genes measured in this study. PTGS1, prostaglandin-endoperoxide synthase 1; PTGS2, prostaglandin-endoperoxide synthase 2; PLA2, phospholipase A2; CYPx, cytochrome P450 family member; ALOX5, arachidonate 5-lipoxygenase; ALOX12, arachidonate 12-lipoxygenase; ALOX15, arachidonate 15-lipoxygenase; TBXA2R, thromboxane A2 (TXA2) receptor; PTGIR, prostaglandin I2 (PGI2) receptor; PTGDR, prostaglandin D2 (PGD2) receptor; PTGFR, prostaglandin F2 (PGF2) receptor; PTGER1-4, prostaglandin E2 (PGE2) receptors 1â€“4.</div></div>